140 related articles for article (PubMed ID: 16963397)
1. Long-term follow-up of children treated for acute lymphoblastic leukemia and the recovery of beta-cell function.
Mohn A; Di Marzio D; De Berardiniis A; Di Marzio A; Capanna R; Fioritoni G; Chiarelli F
Haematologica; 2006 Oct; 91(10):1424-5. PubMed ID: 16963397
[TBL] [Abstract][Full Text] [Related]
2. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
[TBL] [Abstract][Full Text] [Related]
3. [Late neurological complications after termination of treatment of acute lymphoblastic leukemia in children].
Skoczeń S; Balwierz W; Kroczka S; Bańdo B; Kaciński M
Przegl Lek; 2004; 61 Suppl 2():76-80. PubMed ID: 15686052
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone provocation tests and their prediction in the growth of children treated for acute lymphoblastic leukemia.
Papadia C; Naves LA; Motta LD; Barboza Filho RF; Suzuki MT; Casulari LA
Minerva Endocrinol; 2006 Sep; 31(3):211-8. PubMed ID: 17213788
[TBL] [Abstract][Full Text] [Related]
5. Late effects risk profiles using the long-term follow-up guidelines in identical twin survivors of acute lymphoblastic leukemia.
Howell DL; Lew G; Comeaux LG; Meacham LR
Pediatr Blood Cancer; 2007 Sep; 49(3):349-52. PubMed ID: 16602119
[TBL] [Abstract][Full Text] [Related]
6. Height deficit during and many years after treatment for acute lymphoblastic leukemia in children: a review.
Viana MB; Vilela MI
Pediatr Blood Cancer; 2008 Feb; 50(2 Suppl):509-16; discussion 517. PubMed ID: 18064646
[TBL] [Abstract][Full Text] [Related]
7. Treatment for acute lymphoblastic leukemia in children is associated with papillary carcinoma of thyroid, but not with thyroid disfunction.
Neves Mascarenhas A; Papadia C; Alves Aquino C; Oba L; Ferreira M; Casulari LA
Minerva Pediatr; 2006 Oct; 58(5):469-76. PubMed ID: 17008858
[TBL] [Abstract][Full Text] [Related]
8. Incidence of obesity does not appear to be increased after treatment of acute lymphoblastic leukemia in Brazilian children: role of leptin, insulin, and IGF-1.
Papadia C; Naves LA; Costa SS; Vaz JA; Domingues L; Casulari LA
Horm Res; 2007; 68(4):164-70. PubMed ID: 17356293
[TBL] [Abstract][Full Text] [Related]
9. Comparison of long-term neurocognitive outcomes in young children with acute lymphatic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate.
Cohen IJ
J Clin Oncol; 2007 Feb; 25(6):734-5; author reply 735. PubMed ID: 17308283
[No Abstract] [Full Text] [Related]
10. Late cardiac effects of anthracycline containing therapy for childhood acute lymphoblastic leukemia.
Rathe M; Carlsen NL; Oxhøj H
Pediatr Blood Cancer; 2007 Jun; 48(7):663-7. PubMed ID: 17405151
[TBL] [Abstract][Full Text] [Related]
11. Secondary intracranial neoplasms exhibiting features of astrocytoma and neuroblastoma in 2 children treated for acute lymphoblastic leukemia: report of 2 cases.
Vancura RW; Kepes JJ; Newell KL; Ha TM; Arnold PM
Surg Neurol; 2006 May; 65(5):490-4. PubMed ID: 16630913
[TBL] [Abstract][Full Text] [Related]
12. Late effects in long-term survivors after treatment for childhood acute leukemia.
Haddy TB; Mosher RB; Reaman GH
Clin Pediatr (Phila); 2009 Jul; 48(6):601-8. PubMed ID: 19264722
[TBL] [Abstract][Full Text] [Related]
13. Management of acute leukemias: problems with compliance and follow-up.
Shenoy S; Christo GG; Baliga M; Venkatesh A
Indian Pediatr; 1988 Aug; 25(8):740-3. PubMed ID: 3220560
[No Abstract] [Full Text] [Related]
14. Body composition in long-term survivors of childhood acute lymphoblastic leukemia (ALL).
van der Sluis IM; van den Heuvel MM; de Muinck Keizer-Schrama SM
Med Pediatr Oncol; 2003 Jun; 40(6):407. PubMed ID: 12692817
[No Abstract] [Full Text] [Related]
15. Progressive neurocognitive impairment in young adult survivors of childhood acute lymphoblastic leukemia.
Harila MJ; Winqvist S; Lanning M; Bloigu R; Harila-Saari AH
Pediatr Blood Cancer; 2009 Aug; 53(2):156-61. PubMed ID: 19405135
[TBL] [Abstract][Full Text] [Related]
16. Progressive loss of beta-cell function leads to worsening glucose tolerance in first-degree relatives of subjects with type 2 diabetes.
Cnop M; Vidal J; Hull RL; Utzschneider KM; Carr DB; Schraw T; Scherer PE; Boyko EJ; Fujimoto WY; Kahn SE
Diabetes Care; 2007 Mar; 30(3):677-82. PubMed ID: 17327340
[TBL] [Abstract][Full Text] [Related]
17. Long term disease-free survival in acute leukemia patients recovering with increased gammadelta T cells after partially mismatched related donor bone marrow transplantation.
Godder KT; Henslee-Downey PJ; Mehta J; Park BS; Chiang KY; Abhyankar S; Lamb LS
Bone Marrow Transplant; 2007 Jun; 39(12):751-7. PubMed ID: 17450185
[TBL] [Abstract][Full Text] [Related]
18. Influence of catch-up growth on glucose tolerance and beta-cell function in 7-year-old children: results from the birth to twenty study.
Crowther NJ; Cameron N; Trusler J; Toman M; Norris SA; Gray IP
Pediatrics; 2008 Jun; 121(6):e1715-22. PubMed ID: 18519475
[TBL] [Abstract][Full Text] [Related]
19. Persistence of impaired pancreatic beta-cell function in children treated for acute lymphoblastic leukaemia.
Mohn A; Di Marzio A; Capanna R; Fioritoni G; Chiarelli F
Lancet; 2004 Jan; 363(9403):127-8. PubMed ID: 14726167
[TBL] [Abstract][Full Text] [Related]
20. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
